Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
116,964,738
-
Total 13F shares
-
8,294,657
-
Share change
-
+8,293,972
-
Total reported value
-
$132,174,817
-
Price per share
-
$16.32
-
Number of holders
-
35
-
Value change
-
+$132,163,604
-
Number of buys
-
34
Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q4 2014
As of 31 Dec 2014,
Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,294,657 shares.
The largest 10 holders included
Kohlberg Kravis Roberts & Co. L.P., FMR LLC, VHCP Management, LLC, WESTFIELD CAPITAL MANAGEMENT CO LP, JPMORGAN CHASE & CO, PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, BROWN ADVISORY INC, Cormorant Asset Management, LLC, and VANGUARD GROUP INC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.